Yi Sang
Transaction: 05/29/2026
SELL
Change
-800
Price
$82.66
Filing
06/02/2026
Type
SELL
Zimmer Biomet Holdings, Inc.
ZBH • Medical - Devices
$98.07
▼ -0.85 (-0.86%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$19.20B
Growth
8.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.6%Positive revenue growth · 6.2%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.59
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$98.07
Change-0.86%
Shares Out195.80M
Market Cap$19.20B
Enterprise Value$26.25B
52W Range79.12 - 108.29
Beta0.47
P/E25.22
P/S2.28
P/B1.30
P/FCF10.76
EV/Sales3.12
Price$98.07
Change-0.86%
Shares Out195.80M
Market Cap$19.20B
Enterprise Value$26.25B
52W Range79.12 - 108.29
Beta0.47
P/E25.22
P/S2.28
P/B1.30
P/FCF10.76
EV/Sales3.12
EV/EBITDA11.90
EV/FCF14.71
Earnings Yield3.96%
FCF Yield9.29%
Dividend Yield0.98%
Gross Margin61.62%
Oper. Margin16.55%
Profit Margin8.57%
Debt/Eq0.59
Current Ratio1.98
Quick Ratio1.10
Revenue 5Y8.63%
FCF 5Y8.03%
Target$103.11
Target Upside5.14%
Target Median$104.00
Target Range93.00 - 120.00
Volume2.05M
Avg Volume2.34M
EPS Surprise0.23
Investment DNA
How strong this company looks for long-term investors
78
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
68/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Stable or improving margins · 8.6%Positive revenue growth · 6.2%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.59Healthy liquidity · 1.98
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 42 analyst votes · 2026-09-05
67/100
Neutral
Bullish
17
Hold
22
Bearish
3
Price Target
2026-06-25
Low
$83.00
Mean
$96.33
Median
$93.00
High
$120.00
Insider Transactions
Recent executive and insider activity
HAGEMANN ROBERT
Transaction: 05/22/2026
BUY
Change
—
Price
Not reported
Filing
05/27/2026
Type
BUY
HAGEMANN ROBERT
Transaction: 05/22/2026
BUY
Change
—
Price
$85.68
Filing
05/27/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Yi Sang | SELL | -800 | $82.66 | 05/29/2026 | 06/02/2026 |
| HAGEMANN ROBERT | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| HAGEMANN ROBERT | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| HIGGINS ARTHUR J | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| HIGGINS ARTHUR J | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Jafry Syed A. | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Jafry Syed A. | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Kolli Sreelakshmi | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Kolli Sreelakshmi | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Kurdikar Devdatt | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Kurdikar Devdatt | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Shapiro Louis | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Shapiro Louis | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Hilado Maria Teresa | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Hilado Maria Teresa | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| BERNARD BETSY J | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| BERNARD BETSY J | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Farrell Michael J. | BUY | — | Not reported | 05/22/2026 | 05/27/2026 |
| Farrell Michael J. | BUY | — | $85.68 | 05/22/2026 | 05/27/2026 |
| Stellato Paul A | BUY | +9,232 | Not reported | 05/01/2026 | 05/05/2026 |